INTRODUCTION AND AIMS:
Despite more than 1500 randomised trials in HD published over the last decade, substantive improvements in patient outcomes remain to be seen. The inconsistent and selective reporting of highly variable outcomes, and the omission of outcomes that are meaningful to patients and clinicians, can hamper the reliability and comparability of outcomes across trials. The Standardised Outcomes in Nephrology (SONG) -HD initiative aims to establish a set of core outcomes to be reported in all trials in HD based on the shared priorities of patients and health professionals. METHODS: SONG-HD used a 5-phase evidence-based consensus process to first establish the core outcome domains, defined as the most critically important outcomes to be reported in all trials in HD: a systematic review of outcomes reported in trials in HD; focus groups with nominal group technique with patients and caregivers to identify and prioritise outcomes; multi-stakeholder interviews to elicit individual perspectives on outcomes; an international three-round online Delphi survey with patients, caregivers, and health professionals to achieve consensus on critically important outcomes; and a consensus workshop to establish the core outcome set. For each outcome domain, a core outcome measure was then defined using a 4-phase process: a systematic review of outcome measures reported in clinical trials; an international multistakeholder survey to rate and rank outcomes used to assess the outcome domain; consensus workshops to discuss measurement properties and feasibility aspects; and pilot and validation studies to evaluate the identified core outcome measures. RESULTS: In total, 1376 patients, caregivers and health professionals from 73 countries participated in the consensus process to identify the four core outcome domains for HD: fatigue, vascular access, cardiovascular disease, and mortality. For fatigue, the impact of fatigue on life participation was the most critically important dimension (n¼571 participants [44% patients/caregivers]) and a 3-item questionnaire to assess fatigue is currently being validated. For vascular access, the function of the HD access was identified as the most important outcome (n¼1043 participants [25 % patients/ caregivers]) and defined as the need for an intervention to maintain the use of the vascular access for HD. For cardiovascular disease, myocardial infarction and sudden cardiac death were considered of most critical importance (n¼550 participants [25% patients/caregivers]) and the measurement definitions are currently being developed. CONCLUSIONS: Consistent reporting of the core outcome set -fatigue, vascular access function, myocardial infarction, sudden cardiac death, and all-cause mortalityas a minimum in all trials in HD will improve the integrity and comparability of trialbased evidence to inform decision-making in HD. This may help improve outcomes that are meaningful and important to patients and their clinicians. 
The choice of first modality of renal replacement therapy (RRT) to treat end stage kidney disease (ESKD) has long term implications. Preemptive kidney transplantation (PKT) is the gold standard method, and home RRT should be favoured where possible however choice of RRT is influenced by both medical and non-medical factors. We investigated the predictive factors of first RRT modality, focusing on the role of socioeconomic status. METHODS: A retrospective analysis was performed of a prospectively acquired database of adults with CKD in a single nephrology unit from 2006 -2017. PKT was defined as transplant prior to other method of RRT for ESKD, whilst home RRT included transplant, peritoneal dialysis and home haemodialysis (HD) (defined as commencement of home HD within 6 months of ESKD, to allow for training period). The predictors of PKT and home RRT were determined by multiple logistic regression, and competing risks survival analysis was used to determine predictors of progression to ESKD and death. Socioeconomic status was graded by decile of Scottish Index of Multiple Deprivation (SIMD), a postcode derived method of evaluating deprivation with higher number equating to lower deprivation. RESULTS: Of 7765 patients, 1298 required RRT over 6.667.0 years of follow up. 113 received PKT (64 live donor transplants), 166 peritoneal dialysis, 13 home HD, and 1006 hospital HD. There was a greater risk of mortality but not RRT in patients from SIMD3. Live donation was less likely with SIMD3 (64 vs 45%; p¼0.004). PKT patients had higher SIMD (567 vs 465; p¼0.003), were referred to clinic younger (36.5619.5 vs 58.2624.6years; p<0.001) with higher eGFR (39.7639.8 vs 30.5626.3mlmin; p¼0.001), lower proteinuria (766150 vs 1646330mg/mmol; p<0.001) and lower BP (138/82632/17 vs 150/82634/18mmHg; p<0.001); there was lower prevalence of cardiovascular disease (6 vs 22%; p<0.001), malignancy (3 vs 12%; p¼0.004) and diabetes (15 vs 37%; p<0.001). SIMD decile, diabetes, cardiovascular disease, referral age and proteinuria were independent predictors of PKT (R 2 ¼0.22, p<0.001). Home RRT patients had higher SIMD (566 vs 365; p<0.001), lower BMI (26.567.8 vs 27.969.0kg/m 2 ; p¼0.004), were referred to clinic at younger age (46.6626.0 vs 59.3624.2years; p<0.001) with lower proteinuria (876221 vs 1816342mg/mmol; p<0.001); there was lower prevalence of cardiovascular disease (9 vs 25%; p<0.001), diabetes (25 vs 38%; p<0.001) and malignancy (7 vs 13%; p¼0.02). SIMD decile, diabetes, cardiovascular disease, referral age, eGFR and proteinuria, and marital status were independent predictors of home RRT (R 2 ¼0.17; p<0.001).
CONCLUSIONS:
With each increment in SIMD decile, there was a 14% and 16% greater likelihood of PKT and home RRT, respectively. The low uptake of home RRT in lower socioeconomic classes was not explained by a difference in progression to ESKD. Further research is required into the demographic barriers to PKT and home RRT.
FP630 ASSOCIATION OF FRUIT AND VEGETABLE INTAKE WITH ALL-CAUSE MORTALITY IN HEMODIALYSIS PATIENTS (DIET-HD):
A PROSPECTIVE COHORT STUDY
INTRODUCTION AND AIMS:
Higher fruit and vegetable intake is associated with lower vascular and all-cause mortality for the general population. However, whether fruit and vegetable consumption benefits patients treated with hemodialysis is uncertain. We evaluated the association of fruit and vegetable intake with mortality outcomes in adults on hemodialysis.
METHODS:
The DIET-HD study was a prospective cohort study involving 9757 adults treated with hemodialysis. Fruit and vegetable intake was measured using the GA 2 LEN food frequency questionnaire. Cox regression analyses adjusted for sociodemographic and clinical variables and clustered by country were conducted. RESULTS: During a median follow up of 2.7 years (18,666 person-years), there were 2087 deaths, of which 958 were vascular deaths. Overall, higher combined intake of fruit and vegetables was associated with lower risks of non-vascular and all-cause mortality. The risk for vascular mortality was lower with the highest tertile of intake although the 95% confidence interval included the possibility of a null effect. With reference to the lowest tertile of intake (0 to 5.5 servings per week), the adjusted hazards ratios (95% confidence interval) for the middle (5.6 to 10 servings per week) and highest (>10 servings per week) tertiles were 0.88 (0.76-1.02) and 0.77 (0.66-0.91) for non- 
